Navigation Links
Stroke Therapy with Corkscrew Device Most Beneficial, Study Suggests
Date:1/18/2010

border="0" cellspacing="0" cellpadding="0" class="text12px"> 
  • 24 patients who had no treatment entered the hospital with an NIHSS average score of 11.1 and left the hospital with an average score of 8.9, a 20 percent improvement. Two patients died. Patients in this group were those who sought treatment more than six hours after onset of stroke, or who were suffering from stroke caused by bleeding in the brain and therefore were not candidates for intervention.

Clot-busting drugs work by breaking up the clot to open up blood flow. In IV tPA, the drugs are infused intravenously through a standard IV. However, only some of the drugs make their way to the clot to break it up. IV tPA doesn’t require a specialist to administer it, and is the most widely available stroke treatment. IA tPA infuses the clot-busting drugs through a catheter (small tube) directly into the artery where the clot is located, meaning most of the drugs can quickly work to break up the clot. IA tPA must be administered by a physician who specializes in this treatment, such as an interventional radiologist. The clot-removing device is advanced on a wire through a catheter directly to the site of the clot. The device works like a corkscrew to hook into the clot and pull it out. This procedure also must be performed by a specialist.

“All of the treatment groups had improvement, but those in the clot-removing device-only group had the most significant improvement,” said Dr. Stambo. “In most of these patients, blood flow in the brain was re-established quicker than in patients who received the other treatments. If possible, people who show signs of suffering from stroke should get to a stroke center that of
'/>"/>

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Cancer, Heart Disease, Stroke, Diabetes, Chronic Pain and Depression Share a Major Pathology Factor
2. D-Pharm Receives FDA Clearance to Commence a Phase III Trial of DP-b99 in Acute Stroke Patients
3. deCODE and Celera Partner to Expand use of deCODE Risk Markers for Heart Attack, Stroke and Diabetes
4. PAREXEL Establishes Alliance with SITS Network of Clinical Sites Specializing in Stroke Studies
5. deCODE Study Expands Clinical Utility of deCODE AF(TM) for Improving the Diagnosis of Atrial Fibrillation and Preventing Stroke
6. Portola Pharmaceuticals Initiates Phase II Trial of Betrixaban, its Novel Oral Factor Xa Inhibitor for Stroke Prevention in Atrial Fibrillation
7. diaDexus, Inc. and Living Heart Foundation Offer the PLAC(R) Test to Detect Hidden Risk for Heart Attack and Stroke in Retired NFL Players
8. Concentric Medical(R) Announces Co-Marketing Agreement With InTouch Health(R) to Advance Acute Ischemic Stroke Care
9. Lixte Biotechnology Holdings Announces Extension of Its Cooperative Research and Development Agreement With The National Institute of Neurological Disorders and Stroke, National Institutes of Health, for Development of Anti-Brain Cancer Drugs
10. Stable Stroke Patients More Likely to Die From a Nonstroke Cardiovascular Event Than a Further Stroke
11. ThromboGenics Completes Patient Enrolment of MITI IV Trial, a Phase II Study Evaluating the Safety and Preliminary Efficacy of Microplasmin in the Treatment of Acute Stroke
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... , July 29, 2015  Indivior PLC (LON: INDV) ... naloxone nasal spray was accepted and received Priority Review ... the treatment of opioid overdose. This naloxone nasal spray ... formulated for optimal absorption into the nasal mucosa. 1 ... training so individuals may be better equipped to help ...
(Date:7/29/2015)... ... July 29, 2015 , ... CSSi LifeSciences™ formalized ... specializing in Clinical Trial Management. CSSi LifeSciences is specialized in strategic, marketing, and ... PRC Clinical is focused on Clinical Trial Management, Clinical Site Monitoring, and Clinical ...
(Date:7/29/2015)... , ... July 29, 2015 , ... Nearly everyone has ... diseases. Yet few people realize that a rich source of these cells is teeth—baby ... and teeth that need to be pulled to make room for braces. These ...
(Date:7/28/2015)... 28, 2015 People with a common form ... significant and sometimes profound improvements in their hearing and ... to a new multicenter study led by specialists at ... described online ahead of print in the journal The Laryngoscope ... clinics in the United States ...
Breaking Biology Technology:Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 3Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 4Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 5CSSi LifeSciences And PRC Clinical Join Forces To Offer Extended Clinical Trial Services 2CSSi LifeSciences And PRC Clinical Join Forces To Offer Extended Clinical Trial Services 3Advanced Oral and Maxillofacial Surgery (AOMS) in Elmhurst, IL Partners with Provia Labs to make Store-A-Tooth™ Dental Stem Cell Banking Available to their Patients 2Hybrid Cochlear Implants For Common Form Of Hearing Loss May Benefit Millions 2Hybrid Cochlear Implants For Common Form Of Hearing Loss May Benefit Millions 3
... PLYMOUTH MEETING, Pa. , March 15 /PRNewswire-Asia-FirstCall/ -- BMP,Sunstone Corporation ... for the fourth quarter and fiscal year ended, December 31, 2009 . ... -- Revenue increased to $41.5 million, from $36.6 million in the ... -- Gross profit increased 21% to $23.3 million, from $19.2 million ...
... GREAT RIVER, N.Y. , March 15 ... and services for health and human services organizations, today ... generation of the company,s industry leading electronic health record ... software is being demonstrated at the National Council for ...
... ,, NEW YORK , March 15 /PRNewswire-Asia-FirstCall/ -- ... in the U.S. and China , announced,today a change for the Company,s presentation at ... 2010 .,NeoStem,s presentation will now take place at 10:30 a.m. Pacific Time . , ... ...
Cached Biology Technology:BMP Sunstone Reports Fourth Quarter and Full Year 2009 Financial Results 2BMP Sunstone Reports Fourth Quarter and Full Year 2009 Financial Results 3BMP Sunstone Reports Fourth Quarter and Full Year 2009 Financial Results 4BMP Sunstone Reports Fourth Quarter and Full Year 2009 Financial Results 5BMP Sunstone Reports Fourth Quarter and Full Year 2009 Financial Results 6BMP Sunstone Reports Fourth Quarter and Full Year 2009 Financial Results 7BMP Sunstone Reports Fourth Quarter and Full Year 2009 Financial Results 8BMP Sunstone Reports Fourth Quarter and Full Year 2009 Financial Results 9BMP Sunstone Reports Fourth Quarter and Full Year 2009 Financial Results 10BMP Sunstone Reports Fourth Quarter and Full Year 2009 Financial Results 11BMP Sunstone Reports Fourth Quarter and Full Year 2009 Financial Results 12BMP Sunstone Reports Fourth Quarter and Full Year 2009 Financial Results 13BMP Sunstone Reports Fourth Quarter and Full Year 2009 Financial Results 14BMP Sunstone Reports Fourth Quarter and Full Year 2009 Financial Results 15BMP Sunstone Reports Fourth Quarter and Full Year 2009 Financial Results 16Netsmart Announces 'My Avatar' at National Council for Community Behavioral Healthcare Annual Conference 2Netsmart Announces 'My Avatar' at National Council for Community Behavioral Healthcare Annual Conference 3Netsmart Announces 'My Avatar' at National Council for Community Behavioral Healthcare Annual Conference 4Netsmart Announces 'My Avatar' at National Council for Community Behavioral Healthcare Annual Conference 5Netsmart Announces 'My Avatar' at National Council for Community Behavioral Healthcare Annual Conference 6Netsmart Announces 'My Avatar' at National Council for Community Behavioral Healthcare Annual Conference 7NeoStem Announces Presentation Time Change at Roth Capital Partners 22nd Annual OC Growth Stock Conference 2NeoStem Announces Presentation Time Change at Roth Capital Partners 22nd Annual OC Growth Stock Conference 3
(Date:7/9/2015)... 2015  Unchained Labs just can,t get enough ... Avid Nano. Avid Nano designs, develops and manufactures ... Also today, Unchained Labs UNcaged the ... use protein sizing system. The pUNk is a ... size, size distribution, aggregation population and molecular weight. ...
(Date:7/8/2015)...  Trovagene, Inc. (NASDAQ: TROV ), a ... launch of a study that aims to determine ... technology for predicting response to treatment in advanced ... the novel immunotherapy agents Yervoy® (ipilumumab), a CTLA-4 ... 50-patient study will be led by researchers at ...
(Date:7/7/2015)... 7, 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... mobile commerce market announces a revised version of one of its ... will air on CNBC in New York , ... and San Francisco metro areas.    ... Wocket,s ability to replace all the cards in your wallet and ...
Breaking Biology News(10 mins):Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3
... (ACS) Weekly PressPac from the Office of Public ... journals and Chemical & Engineering News ., ... Chemical Society as the source for this information. ... #1 FOR IMMEDIATE RELEASE Gene - ...
... , Gene therapy is the introduction of genetic material into ... effect. In recent years, it has been shown that ... cure several fatal diseases for which there is no attractive ... diseases, but also for other diseases that affect heart, brain ...
... Institutes of Health have identified a gene associated with ... attacks, irresistible bouts of sleep that can strike at ... has a known role in the immune system, which ... turns against the body,s own tissues, plays an important ...
Cached Biology News:American Chemical Society's weekly PressPac -- April 29, 2009 2American Chemical Society's weekly PressPac -- April 29, 2009 3American Chemical Society's weekly PressPac -- April 29, 2009 4American Chemical Society's weekly PressPac -- April 29, 2009 5American Chemical Society's weekly PressPac -- April 29, 2009 6Moving gene therapy forward with mobile DNA 2Genetic study confirms the immune system's role in narcolepsy 2Genetic study confirms the immune system's role in narcolepsy 3
Request Info...
...
... REact Buffers are supplied as 10X concentrated solutions. ... of each of the REact buffers and one ... SetConsists of four 1 ml vials of REact ... 2 Buffer four 1 ml vials of REact ...
This Malachite Green Phosphate Detection Kit...
Biology Products: